文献速递类风湿关节炎

多重长期疾病如何影响早期类风湿关节炎的疾病经济负担

How do multiple long-term conditions impact on the cost-of-illness in early rheumatoid arthritis?
PubMed 文献 · RMD Open · 2022-01-01

苏格兰早期类风湿关节炎研究纳入818例新发类风湿关节炎成人,按合并长期疾病数量分为单纯类风湿关节炎、类风湿关节炎合并1种长期疾病和类风湿关节炎合并多重长期疾病,估算直接与间接成本。合并多重长期疾病者年均直接成本为4444英镑,约为合并1种长期疾病者(2184英镑)的两倍、无长期疾病者(919英镑)的近五倍;间接成本为842英镑,为单纯类风湿关节炎者(530英镑)的3.1倍。

要点

  • 早期类风湿关节炎合并多重长期疾病者年均直接成本4444英镑,约为合并1种长期疾病者的两倍。
  • 合并多重长期疾病者直接成本约为无长期疾病者的近五倍。
  • 合并多重长期疾病者间接成本842英镑,为单纯类风湿关节炎者的3.1倍。

核心结论

  • 多重长期疾病在类风湿关节炎早期即影响疾病经济负担,合并长期疾病与直接成本和间接成本显著增加相关。

研究设计与样本

  • 苏格兰早期类风湿关节炎研究为全国性新发类风湿关节炎成人队列,共818名参与者有可用数据。
  • 直接成本按卫生资源利用乘以相关单位成本估算,间接成本按健康问题导致的生产力损失测量。
  • 采用两部分模型并校正年龄、性别、基线功能残疾和健康相关生活质量,Charlson合并症指数评分基于ICD-10诊断计算。
  • 按共存长期疾病数量将个体定义为单纯类风湿关节炎、类风湿关节炎合并1种长期疾病和类风湿关节炎合并多重长期疾病。

主要发现

  • 合并多重长期疾病者年均直接成本为4444英镑(95%CI 3100至6371),合并1种长期疾病者为2184英镑(95%CI 1596至2997),无长期疾病者为919英镑(95%CI 694至1218)。
  • 合并多重长期疾病者间接成本为842英镑(95%CI 377至1521),单纯类风湿关节炎者为530英镑(95%CI 273至854),前者为后者的3.1倍。
  • 直接成本相对占比随长期疾病类别增加而升高,范围为77.2%至84.1%。
  • 除长期疾病外,成本亦随年龄增加而升高,且无论长期疾病类别如何男性成本更高。

关键数值与推荐

  • 合并多重长期疾病者年均直接成本4444英镑(95%CI 3100至6371),约为合并1种长期疾病者2184英镑(95%CI 1596至2997)的两倍。
  • 合并多重长期疾病者年均直接成本4444英镑(95%CI 3100至6371),约为无长期疾病者919英镑(95%CI 694至1218)的近五倍。
  • 合并多重长期疾病者间接成本842英镑(95%CI 377至1521),为单纯类风湿关节炎者530英镑(95%CI 273至854)的3.1倍。
  • 直接成本相对占比随长期疾病类别增加而升高,范围为77.2%至84.1%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Multiple long-term conditions (MLTCs) are prevalent in rheumatoid arthritis (RA) and associated with worse outcomes and greater economic burden. However, little is known about the impact of MLTCs on the cost-of-illness (COI) in early RA, including direct and indirect costs. The objective of this study was to quantify this impact on COI. METHODS: The Scottish Early Rheumatoid Arthritis study is a national cohort of adults with new-onset RA. Direct costs were estimated applying relevant unit costs to health resource utilisation; indirect costs were measured by productivity loss due to health conditions. Two-part models were used, adjusting for age, gender, baseline functional disability and health-related quality of life. The Charlson Comorbidity Index score was calculated using ICD-10 diagnoses. Individuals were defined as 'RA alone', 'RA plus LTC' and 'RA plus MLTCs' according to the number of coexisting LTCs. RESULTS: Data were available for 818 participants. Average annualised direct costs incurred by people with early RA plus MLTCs (£4444; 95% CI £3100 to £6371) were twice as, and almost five times higher than, those with a single LTC (£2184; 95% CI £1596 to £2997) and those without LTC (£919; 95% CI £694 to £1218), respectively. Indirect costs incurred by RA plus MLTCs (£842; 95% CI £377to £1521) were 3.1 times higher than RA alone (£530; 95% CI £273to £854). The relative proportion of direct costs increased with LTC category, ranging from 77.2% to 84.1%. In addition to increased costs with LTCs, costs also increased with age and were higher for men regardless of LTC category. CONCLUSIONS: MLTCs impact on COI early in the course of RA. The presence of LTCs is associated with significant increases in both direct and indirect costs among people with early RA.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Hsieh PH, Geue C, Wu O, et al. How do multiple long-term conditions impact on the cost-of-illness in early rheumatoid arthritis? RMD Open. 2022. PMID: 36104116. doi:10.1136/rmdopen-2022-002454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。